ACTRN12615000587505招募中未知
The Residential Ocular Care Study: A Multi-Centered, Randomized Controlled Clinical Trial comparing the effectiveness of an innovative and comprehensive new eye care model with usual care for individuals in Residential Aged Care Facilities
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 395
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Inclusion Criteria
- •(i) Presenting distance vision of 6/15 or less and/or Near vision of N8 or less in both eyes
- •(ii) Ability to speak English
- •(iii) People deemed not cognitively impaired as determined by the Psychogeriatric Assessment Scale (PAS) questionnaire. A score of <15 in the PAS is deemed eligible.
- •(iv) Ability to undergo visual acuity testing and provide reliable results
排除标准
- •Exclusion Criteria
- •(i) Presenting distance vision of 6/12 or better and/or Near vision of better than N8 in both eyes
- •(ii) Inability to speak English
- •(iii)People with a cognitive impairment as determined by the Psychogeriatric Assessment Scale (PAS) questionnaire. A score of >15 in the PAS is deemed ineligible.
- •(iii) Non-english speaking residents
- •(iv) inability to be tested for vision
- •(v) contraindication(s) as indicated by general practitioner responsible for residents care.
研究者
相似试验
已完成
3 期
To assess the ability of retina specialists to successfully administer Aflibercept in eye.CTRI/2023/10/059113Biosimilar collaborations Ireland Limited35
已完成
不适用
A multicenter study on the evaluation of eye lens doses for medical staff performing non-vascular interventional radiology proceduresot applicableJPRN-UMIN000014941Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University100
尚未招募
Unknown
Ocular morbidity and its association with Indoor air pollution in adult women population of a rural area in DelhiCTRI/2024/05/066912MAULANA AZAD MEDICAL COLLEGE
已完成
3 期
A 3-year, multi-center study to evaluate optical coherencetomography as an outcome measure in patients with multiple sclerosischronic impairment of the central nervous system1003006410007951multiple sclerosisNL-OMON37946ovartis20
进行中（未招募）
1 期
A 3 year study to determine if optical coherence tomography can be used to measure disease progression in patients with multiple sclerosisMedDRA version: 15.0Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersmultiple sclerosisEUCTR2011-001437-16-DEovartis Pharma Services AG422